AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

We came across a bullish thesis on Bio-Techne Corporation (TECH) on scuttleblurb’s Substack. In this article, we will ...

Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and therefore flagged by the Imperva network. Imperva displays this page for you ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, iteration and aligned resources are all critical drivers of breakthroughs ...

After disappointing trial results for its melanoma and ovarian cancer treatments, Mural Oncology announced Wednesday it will cut about 104 positions, or about 90% of its workforce. The company ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against ...

and stands eleventh on our list among the 12 most promising biotech stocks according to Wall Street analysts. The business has solid foundations, despite poor sales and slow market uptake of its ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today reported business highlights for the ...

“People invested so heavily in biotechnology companies during the pandemic and then, as interest rates started to come up, the whole business model of, ‘Give us money for 10 years and then we ...

In Massachusetts, biotech startups benefited from improving conditions in three key areas of the business: venture capital funding, mergers and acquisitions, and initial public offerings.